John Locke Foundation: Prudent Policy / Impeccable Research - Volume DCX | Eastern NC Now

We will offer this allotment of three with more to come; some old, most new, but all quite informative, and, moreover, necessary to understanding that in North Carolina, there is a wiser path to govern ourselves and our People.

ENCNow
Publisher's Note: We want our readers to understand that there is wise policy afoot here in North Carolina, and to that end, we offer these excellent videos from our associates, in prudent policy research, at the John Locke Foundation.

    We will offer this allotment of three with more to come; some old, most new, but all quite informative, and, moreover, necessary to understanding that in North Carolina, there is a wiser path to govern ourselves and our People.



Locke’s Andy Jackson Assesses Bill Targeting Collusive Lawsuit Settlements


Dr. Andy Jackson, director of the Civitas Center for Public Integrity at the John Locke Foundation, discusses a bill designed to fight collusive lawsuit settlements.


Carolina Journal’s Ray Nothstine Urges Increased N.C. Protection Against Eminent Domain Abuse


Ray Nothstine, Carolina Journal opinion editor, explains why N.C. property owners need more protection against eminent domain abuse.


Locke’s Joseph Coletti Pans Cooper’s Tax Credit Proposals


Joseph Coletti, John Locke Foundation senior fellow in fiscal studies, discusses Gov. Roy Cooper’s proposed tax credits.

Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published )
Enter Your Comment ( text only please )




GOP Lawmakers Move Forward Bills To ‘Restore Trust’ in Election System After 2020 Debacle John Locke Foundation Guest Editorial, Editorials, Op-Ed & Politics My Spin: What’s in a Name?


HbAD0

Latest Op-Ed & Politics


HbAD1

"Your faith will go quiet when you need it loud. Tend to your faith, not just when you’re broken, but when you’re whole."
illegal alien "asylum seeker" migrants are a crime wave on both sides of the Atlantic

HbAD2

 
 
Back to Top